Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Mootral introduces new methane reduction technology, doubling efficacy using a well-known natural molecule
2023-12-04 20:00
Latest Updates of Viva's Portfolio Companies
2023-12-04 17:55
Cigna Healthcare Research: People in Hong Kong Have the Lowest Vitality Score in APAC
2023-12-04 17:34
Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology
2023-12-04 16:39
MeltMed® Rings in the Holidays with Reduced Pricing and New NAD+ Starter Packs
2023-12-04 15:01
First Patient Dosed in Phase Ⅲ Study of JSKN003 for the Treatment of Advanced HER2-Low Breast Cancer
2023-12-04 14:51
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics
2023-12-04 13:19
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent
2023-12-04 13:00
VISTA Eye Specialist introduces CLEAR - a new generation eye surgery to help patients be glasses free again.
2023-12-04 09:38
The 3rd International Medical Innovation and Cooperation Forum convenes in Fangchenggang
2023-12-04 08:59
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China
2023-12-04 08:58
"No Perchlorate, Yes Non-electrolysis"...CJ FNT Introduces Natural Cysteine
2023-12-04 08:00
Media Tour Witnesses Chinese Modernization in Hainan FTP
2023-12-03 16:07
Physical climate risk analysis of over 200 000 hospitals exposes risk of shutdowns from extreme weather
2023-12-03 02:00
The Grand Opening of HKSH's Proton Therapy Centre Marks a Significant Advancement in Precision Cancer Treatment in Hong Kong
2023-12-02 19:22
The highest incidence of OHCA is at home, with 3 cases of young OHCA occurring at home every week.
2023-12-01 21:29
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS
2023-12-01 21:00
Gates Foundation Announces Partnership with United Arab Emirates to Accelerate Action on Climate and Strengthen Food Systems Through Investment in Agricultural Innovation
2023-12-01 18:30
So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business
2023-12-01 18:00
The Shanghai Cooperation Organization Traditional Medicine Forum opened
2023-12-01 17:49
1
65
66
67
68
69
1531